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Abstract
Background Life-threatening acute lung injury due to combat
and/or terror attacks is associated with high mortality. The
successful management includes the use of “rescue” extracor-
poreal lung assist and early transport by aeromedical
evacuation teams.
Aims Description of the pre-hospital support of a severely
injured soldier with a pumpless extracorporeal arterio-
venous lung assist in critical hypercapnia/hypoxemia.
Method A Britishsoldier sufferedfrom severegunshot injuries
to the chest and abdomen in Afghanistan. After traumatic
pneumonectomy, he developed critical hypercapnia/hypox-
emia. He was mechanically ventilated and supported with a
pumpless interventional extracorporeal lung assist (iLA,
Novalung, Talheim, Germany) and transferred to Germany.
Results A sufficient CO2 extraction and improvement in
oxygenation enabled the safe transportation and lung protec-
tive ventilation. Weaning from mechanical ventilation was
promoted by the application of a new neurally adjusted
ventilatory assist (NAVA). The patient recovered, and he left
Germany in stable condition.
Conclusion Novel techniques in extracorporeal lung assist
and in ventilatory support may help save lives even in
disaster medicine.
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Neurally adjusted ventilatory assist
A 19-year-old British soldier sustained gunshot injuries to the
chest and abdomen in Afghanistan. He arrived to the
emergency room awake, but haemodynamically unstable.
He was emergently intubated and transferred to the operating
room. Extended exploration revealed right haemopneumo-
thorax, left pneumothorax, grade IV liver injury with
disruption of the right lobe, extensive destruction of the right
lung and diaphragm injury. After laparotomy, portal triad
occlusion was performed, and the haemorrhage was con-
trolled with vessel ligation, abdominal packing and zeolite
(QuikClot, Z-Medica, Wallingford, CT). A traumatic pneu-
monectomy was performed with staples, and the chest and
abdomen were packed and temporarily closed after insertion
of chest tubes and drains. The patient received 52 units of
packed red blood cells and 52 units of fresh frozen plasma.
After the surgery, the haemodynamic situation stabilized,
but the patient developed severe hypercapnia (PaCO2
>100 mmHg) with acidosis (arterial pH<7.1) and hypoxemia
(PaO2 66 mmHg with FIO2 0.8). The medical staff decided
to support him with a pumpless extracorporeal arterio-
venous interventional lung assist (iLA, Novalung, Talheim,
Germany) to enable a transfer to a specialized centre
(Regensburg University Hospital) for further treatment, since
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injured soldiers from Iraq [1]. In brief, iLA is a single-use
ultracompact extrapulmonary gas exchange system perfused
by the heart (see the extensive description elsewhere [2]).
Apart from an oxygen supply (10–12 l min
−1), the system
does not require additional energy or substrate sources. A
passive femo-femoral shunt flow generated by the arterial
blood pressure through a lung assist device (iLA NovaLung®
GmbH, Talheim, Germany) produces sufficient CO2 extrac-
tion and a moderate improvement in arterial oxygenation at a
flow rate of approximately 1.0–1.5 l min
−1. An average
driving pressure difference of 60–80 mmHg (femoral artery-
femoral vein) is mandatory. The entire effective gas
exchange surface area amounts to 1.3 m
2. Integration of a
heat exchanger is not necessary as temperature loss due to
convection is negligible. iLA is suitable for patients with
potentially reversible respiratory failure resulting from, for
instance, trauma, aspiration, pancreatitis and sepsis. Contra-
indication for the application of the system is a haemody-
namic depression of cardiac origin.
In order to connect the ILA to the patient, a special
percutaneous cannulation system was developed fulfilling
the following conditions: implantable with the Seldinger
technique, cannulae walls extremely thin to optimize low
resistance to flow and availability in various diameters (13–
17 F). In every individual case, the size of the cannula used
(arterial: 13–15 F, venous: 17–19 F) is determined by the
diameter of the vessel to be cannulated. Prior to puncture of
the femoral artery, the diameter should be measured by
ultrasound sonography. After cannulation of the femoral
artery and vein, the system is connected, primed with
hydroxyethyl starch (250 ml) and then the circulation is
started (Fig. 1). Functional control is achieved through a
monitoring device (“Clamp On” Sensor, NovaLung®
GmbH, Talheim, Germany) that calculates blood flow
through the system by means of ultrasound technology.
The iLA was placed in the field hospital, and the patient
was then transported from Afghanistan to Germany by a
specialized team trained in the use of iLA.
The patient arrived in critical condition. A CT scan
demonstrated the post-pneumonectomy cavity (Fig. 2),
patchy contralateral pulmonary consolidation and retained
intraabdominal packing. Over the subsequent 48 h, the
patient continued to be ventilated in a lung-protective
mode (tidal volume 220 ml, positive end expiratory
pressure 12 cm H2O) with the result of only moderate
hypercapnia (PaCO2 56 mmHg) because of the CO2
removal capacity of the iLA system. Repeat thoracotomy
w a sp e r f o r m e d ,a n dt h eb r o n c h u ss t u m pw a sr e - s t a p l e d ,a
biliary duct leak was drained externally, and the patient
recovered slowly.
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Fig. 1 A severely injured soldier
with acute respiratory failure and
the pumpless interventional lung
assist (iLA)
Fig. 2 Chestimagingbycomputertomographydemonstratingatraumatic
right pneumonectomy with packing and injured lung tissue on the left
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continued iLA, but the mechanical ventilatory support
could not be diminished: we observed severe fatigue
syndrome of the remaining left diaphragm and a
catabolic state. An augmented spontaneous breathing
trial resulted in patient-ventilator asynchrony and critical
deterioration of the gas exchange. After tracheostomy, we
decided to apply a new neurally adjusted ventilatory
assist (NAVA, Maquet, Sweden), which delivers pressure
in proportion to the electrical activity of the diaphragm,
assessed by a special nasogastric tube with electrodes [3].
The patient was successfully weaned within 10 days, and
the iLA system was removed. The patient recovered, and
he was transferred to a Military Hospital spontaneously
breathing in stable condition.
Discussion
In Iraq and Afghanistan, soldiers are still exposed to combat
and/orterrorattacks.Successfulcombatcarerequiresefficient
casualtycarecentersandanearlytransportofcriticallyinjured
patients by aeromedical evacuation teams. The use of
extracorporeal lung assist by acute lung rescue teams has
been reported in soldiers suffering from life-threatening acute
lung injury [4]. We believe that our patient would not have
survived the transport without early implementation of iLA
“inthefield”.ThesystemprovidesexcellentCO2 elimination,
allowing lung protective ventilation of the remaining lung.
We believe that the addition of a novel ventilation mode
(NAVA), characterized by proportional unloading of the
respiratory muscles, improved subject-ventilator synchrony,
minimized inspiratory pressures and enabled successful
weaning in a critical limitation of breathing capacity without
perspective of early lung transplantation. We conclude that
novel techniques in ventilatory support save lives even in
disaster medicine.
Contributions
All authors were involved in managing the patient,
discussing and planning logistic aspects of transportation
and writing the report.
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